Why Highlight HBOT for Pelvic, Vulvar, and Peritoneal Radiation Effects?
Gynecologic Cancer Awareness Month is a time to discuss more than cancer detection and treatment. It is also an opportunity to address health problems that may continue after cancer therapy has ended and cutting-edge therapies that work. For some women, radiation treatment can cause delayed injury to healthy tissue within the treated area. These complications may develop months or years later and can affect daily function, comfort, and quality of life. Delayed radiation tissue injury can involve several structures within the pelvis. Depending on the radiation field, affected areas may include the vagina, vulva, bladder, rectum, bowel, and surrounding soft tissues. Symptoms can include persistent pain, bleeding, ulceration, tissue breakdown, urinary problems, bowel problems, or changes in normal tissue function.
For selected patients with documented late radiation tissue injury, Hyperbaric Oxygen Therapy (HBOT) may be used to support healing. HBOT is not a treatment for gynecologic cancer itself. Its role is to address certain tissue injuries that remain after radiation treatment. Clinical guidelines and published research support its use for selected cases of delayed radiation injury, although the strength of evidence differs between conditions.
What Happens to Healthy Tissue After Radiation?
The good news is radiation works. Radiation works by damaging cancer cells, but normal cells within the treatment field can sometimes also sustain injury. Some early effects occur during or soon after treatment. Delayed radiation injury is different. It can develop long after radiation has been completed.
One major component is damage to small blood vessels. Radiation can cause progressive changes in the microvasculature and surrounding connective tissue. Over time, this may reduce the tissue's ability to receive adequate blood flow and repair itself after injury. Fibrotic changes can further alter the structure and function of the affected area.
This creates a difficult healing environment. Tissue that has already been damaged may have limited capacity to respond to another injury, surgical procedure, infection, or chronic breakdown.
The process is more complex than simply having “low oxygen.” Radiation injury can involve vascular changes, fibrosis, cellular dysfunction, and impaired tissue repair. These changes help explain why symptoms can appear long after the original cancer treatment.
What Is Delayed Radiation Tissue Injury?
Delayed radiation tissue injury is a recognized complication of radiation therapy. It refers to tissue damage that develops or persists after the acute effects of radiation have passed.
Pelvic radiation injuries can take different forms. A patient may develop radiation cystitis involving the bladder, radiation proctitis involving the rectum, or soft-tissue injury involving the vagina, vulva, or surrounding pelvic structures. Severe cases can involve ulceration, necrosis, fistulas, or wounds that are difficult to heal.
The timing can make diagnosis challenging. A woman may complete cancer treatment, remain stable for a period, and later develop bleeding, pelvic pain, tissue breakdown, or other symptoms. The delayed onset does not rule out radiation as the cause.
A careful medical evaluation is therefore essential. Symptoms after cancer treatment can have many causes, including infection, recurrent disease, surgical complications, and other medical conditions. Establishing the cause of the problem is the first step before considering HBOT.
Which Gynecologic Areas May Be Affected?
The tissues at risk depend on the cancer being treated and the location and dose of radiation.
Pelvic tissues may include the bladder, rectum, vagina, reproductive structures, and surrounding soft tissue. Injury can affect urinary, bowel, sexual, or pelvic function.
Vulvar and vaginal tissues can develop radiation-related fibrosis, ulceration, bleeding, pain, or tissue breakdown. A 2025 retrospective study of 19 women with vaginal late radiation tissue injury found that 15 patients reported improvement in at least one vaginal symptom after HBOT. Improvements were reported in areas including ulceration, dyspareunia, pain, and anatomical changes.
Peritoneal and nearby abdominal tissues may also be exposed during radiation treatment for certain gynecologic cancers. The specific effects depend on the treatment field and the structures that received radiation. It is therefore more useful to discuss radiation injury according to the affected tissue than to assume that every patient will experience the same complication.
How Does HBOT Support Radiation-Injured Tissue?
Medical-grade HBOT places the patient in a slightly pressurized hard chamber while the patient breathes 100% medical-grade oxygen. Increased pressure raises the amount of oxygen dissolved in the blood and then in the plasma and increases oxygen availability to tissues up to four times further into the tissues.
For radiation-injured tissue, this can create a healing environment that differs from the chronically compromised state produced by radiation damage. HBOT can stimulate biological responses involved in tissue repair, including angiogenesis and improved vascularization. These effects are part of the reason HBOT is used for selected delayed radiation injuries.
The purpose is not to remove the original radiation damage or reverse cancer. The treatment is directed toward the late tissue injury and the impaired healing environment that can follow radiation therapy.
This is why patient selection matters. HBOT is not a general treatment for every symptom that occurs after cancer treatment. It is considered for specific radiation-related injuries that meet appropriate clinical criteria.
Case Study 1: HBOT and Advanced Wound Care After Vulvovaginal Cancer Treatment
A retrospective case series examined five patients who developed difficult wound complications after treatment for lower genital cancers. The patients had undergone major cancer surgery, pelvic radiation therapy, or both, followed by wound dehiscence or late radiation-related tissue necrosis. Their treatment included advanced wound care combined with Hyperbaric Oxygen Therapy.
The patients had a mean age of 63 years. Four had squamous cell carcinoma, while one had vaginal adenocarcinoma associated with previous diethylstilbestrol exposure. Three patients had undergone radical vulvectomy, and all five had received pelvic radiation therapy before developing wound complications.
Each patient received an average of 58 HBOT sessions as part of the wound-management plan. At the final wound follow-up after completing HBOT, the average reduction in wound area was 76%, with individual reductions ranging from 42% to 95%. Complete tissue granulation or significant improvement in radiation-related tissue necrosis was reported in all five patients. The average follow-up period was approximately five months.
The findings show how HBOT may be incorporated with advanced wound care for selected patients who develop difficult-to-heal wounds or late radiation tissue injury after gynecologic cancer treatment. The case series is particularly relevant to vulvar and vaginal complications following surgery and pelvic radiation.
The results should be interpreted carefully. For patients with confirmed radiation-related tissue injury, the case series provides a clinical example supporting further consideration of HBOT within an individualized medical treatment plan.
For more detailed clinical information, you can review the following case study and research resources on HBOT for radiation-related wound complications after gynecologic cancer treatment.
Case Study 2: https://pmc.ncbi.nlm.nih.gov/articles/PMC3185899/
Case Study 3: https://www.ajog.org/article/S0002-9378(11)91421-5/abstract
Why Can Radiation Injuries Appear Years Later?
Radiation injury does not always follow the same timeline as the original cancer treatment.
Some tissue changes develop gradually. Damage to small blood vessels and connective tissue can continue to affect the treated area after radiation has ended. A patient may therefore develop symptoms long after completing therapy.
This delayed pattern is clinically important because patients and healthcare providers may not immediately connect a new symptom with radiation received 3, 5, or 7 years earlier. A history of pelvic radiation should be considered during the evaluation of unexplained bleeding, persistent pelvic pain, tissue breakdown, urinary problems, or bowel symptoms.
The purpose of the evaluation is not to assume that radiation is responsible. It is to determine whether radiation injury is actually present and whether another condition needs to be addressed.
Who May Be Considered for HBOT?
HBOT should begin with a medical diagnosis and an assessment of the patient's overall condition.
A physician may review the original cancer treatment, radiation history, affected tissues, current symptoms, previous interventions, medications, and other medical conditions. Depending on the problem, evaluation may involve specialists such as a gynecologic oncologist, gynecologist, urologist, colorectal specialist, or surgeon.
Patients should also understand the specific goal of HBOT. Treatment may be considered for a documented radiation-related wound, necrosis, bleeding, or other late tissue complication. The treatment plan should be based on the clinical problem rather than simply on a history of having received radiation.
A medical-grade hyperbaric program should provide physician-directed care, trained hyperbaric personnel, appropriate patient monitoring, and equipment capable of delivering established HBOT treatment protocols.
Closing Note:
Gynecologic Cancer Awareness Month provides an opportunity to recognize the long-term health issues that can follow cancer treatment. Delayed radiation tissue injury is one of those complications. The injury can affect different pelvic and gynecologic tissues, and its symptoms may appear long after radiation therapy has ended. For patients with confirmed late radiation tissue injury, clinical research supports consideration of HBOT as a treatment option, particularly for difficult-to-heal soft-tissue complications. The available evidence is encouraging, making proper diagnosis and patient selection essential. At Advanced Hyperbaric Recovery Inc., medical-grade Hyperbaric Oxygen Therapy is provided within a physician-directed clinical setting. Patients considering HBOT for radiation-related complications should first undergo an appropriate medical evaluation to determine whether their condition fits an established indication and whether HBOT is appropriate for their individual needs.
For women experiencing persistent pelvic, vulvar, vaginal, urinary, bowel, or other symptoms after radiation treatment, discussing the possibility of delayed radiation tissue injury with a qualified healthcare provider can be an important step toward identifying the right treatment approach, alleviating suffering, and improving their quality of life.
Frequently Asked Questions:
-
Yes. Radiation can damage healthy tissue within the treatment area. Delayed effects may include reduced blood supply, fibrosis, poor healing, bleeding, pain, ulceration, and tissue breakdown that develops months or years after treatment.
-
Medical-grade HBOT supports healing in selected patients with documented delayed radiation tissue injury. Treatment increases oxygen availability, reduces inflammation, and can support biological processes involved in tissue repair and new blood-vessel formation.
-
HBOT may be considered for certain difficult-to-heal radiation injuries involving pelvic soft tissue, bladder, bowel, vaginal tissue, vulvar tissue, and other affected structures. Treatment depends on the diagnosis and individual medical assessment.
-
No. HBOT does not remove tumors or replace cancer-directed treatments such as surgery, chemotherapy, or radiation therapy. Its role is to support healing of certain tissue injuries that develop after radiation treatment.
-
Doctors review the patient's cancer treatment history, symptoms, affected tissue, medical conditions, and diagnosis. They then determine whether the radiation injury matches an established HBOT indication and whether treatment is medically appropriate.
If you would like more information or to schedule a comprehensive consultation with one of our Hyperbaric physicians, please call 415-785-8652 now.
